2024

• Gjorup, C., Woodford, R., Li, I., Carlino, M., Ch'ng, S., Chung, D., Hsiao, E., Lo, S., London, K., Long, G., Menzies, A., Nieweg, O., Pennington, T., Rtshiladze, M., Saw, R., Scolyer, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Varey, A., van Akkooi, A. (2024). ASO Visual Abstract: Role of Concurrent Ultrasound Surveillance of Sentinel Node‑Positive Node Fields in Melanoma Patients Having Routine Cross‑Sectional Imaging. Annals of Surgical Oncology, 31(3), 1882-1883. [More Information]
• Menzies, A., Emmett, L., Kapoor, R., Rawson, R., Stretch, J., Thompson, J., Spillane, A., Rizos, H., Scolyer, R., Long, G., Lo, S., Saw, R., Gonzalez, M., Ch'ng, S., Nieweg, O., Shannon, K., Ferguson, P., et al (2024). Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma. Annals of Oncology. [More Information]
• Varey, A., Li, I., El Sharouni, M., Simon, J., Dedeilia, A., Ch'ng, S., Saw, R., Spillane, A., Shannon, K., Pennington, T., Rtshiladze, M., Stretch, J., Nieweg, O., van Akkooi, A., Scolyer, R., Long, G., Thompson, J., Lo, S., et al (2024). Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator. Journal of Clinical Oncology, 42(10), 1169-1180. [More Information]

2023

• Holtkamp, L., Lo, S., Thompson, J., Spillane, A., Stretch, J., Saw, R., Shannon, K., Nieweg, O., Hong, A. (2023). Adjuvant radiotherapy after salvage surgery for melanoma recurrence in a node field following a previous lymph node dissection. Journal of Surgical Oncology, 128(1), 97-104. [More Information]
• Schoenfeldt, T., Thompson, J., Lo, S., Drzewiecki, K., Stretch, J., Saw, R., Spillane, A., Shannon, K., Uren, R., Chakera, A., Nieweg, O. (2023). ASO Visual Abstract: Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma. Annals of Surgical Oncology, 30(4), 2362-2363. [More Information]
• Holtkamp, L., Lo, S., Drummond, M., Thompson, J., Nieweg, O., Hong, A. (2023). Hypofractionated or Conventionally Fractionated Adjuvant Radiotherapy After Regional Lymph Node Dissection for High-Risk Stage III Melanoma. Clinical Oncology, 35(1), e85-e93. [More Information]
• Miller, J., Lo, S., Nosrati, M., Stretch, J., Spillane, A., Saw, R., Shannon, K., Nieweg, O., Ch'ng, S., Kim, K., Thompson, J., Scolyer, R., et al (2023). Improving Selection for Sentinel Lymph Node Biopsy Among Patients With Melanoma. JAMA Network Open, 6(4), e236356. [More Information]
• Law, C., Cust, A., Smit, A., Trevena, L., Fernandez Penas, P., Nieweg, O., Menzies, A., Wordsworth, S., Morton, R. (2023). Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine, 25(12), 100970. [More Information]
• Schoenfeldt, T., Thompson, J., Lo, S., Drzewiecki, K., Stretch, J., Saw, R., Spillane, A., Shannon, K., Uren, R., Chakera, A., Nieweg, O. (2023). Prognostic Significance and Management of Sentinel Nodes in the Triangular Intermuscular Space of Patients with Melanoma. Annals of Surgical Oncology, 30(4), 2354-2361. [More Information]
• Gjorup, C., Woodford, R., Li, I., Carlino, M., Ch'ng, S., Chung, D., Hsiao, E., Lo, S., London, K., Long, G., Menzies, A., Nieweg, O., Pennington, T., Rtshiladze, M., Saw, R., Scolyer, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Varey, A., van Akkooi, A. (2023). Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging. Annals of Surgical Oncology, 31(3), 1857-1864. [More Information]

2022

• Lawless, A., Coker, D., Lo, S., Ahmed, T., Scolyer, R., Ch'ng, S., Nieweg, O., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Saw, R. (2022). ASO Visual Abstract: Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-transit Melanoma Metastases. Annals of Surgical Oncology, 29(11), 7031-7032. [More Information]
• Lawless, A., Coker, D., Lo, S., Ahmed, T., Scolyer, R., Ch'ng, S., Nieweg, O., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Saw, R. (2022). Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases. Annals of Surgical Oncology, 29(11), 7019-7028. [More Information]
• Newell, F., Johansson, P., Wilmott, J., Nones, K., Lakis, V., Pritchard, A., Lo, S., Rawson, R., Kazakoff, S., Colebatch, A., Ferguson, P., Vergara Correa, I., Long, G., Nieweg, O., Shivalingam, B., Stretch, J., Spillane, A., Saw, R., Shannon, K., Thompson, J., et al (2022). Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes. Cancer Discovery, 12(12), 2856-2879. [More Information]
• Dieng, M., Turner, R., Lord, S., Einstein, A., Menzies, A., Saw, R., Nieweg, O., Thompson, J., Morton, R. (2022). Cost-Effectiveness of PET/CT Surveillance Schedules to Detect Distant Recurrence of Resected Stage III Melanoma. International Journal of Environmental Research and Public Health, 19(4), 2331. [More Information]
• El Sharouni, M., Scolyer, R., van Gils, C., Ch'ng, S., Nieweg, O., Pennington, T., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Lo, S., et al (2022). Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patients. European Journal of Cancer, 167, 133-141. [More Information]
• Seviiri, M., Scolyer, R., Bishop, D., Newton-Bishop, J., Iles, M., Lo, S., Stretch, J., Saw, R., Nieweg, O., Shannon, K., Spillane, A., Thompson, J., Long, G., et al (2022). Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation setting. Journal of Translational Medicine, 20(1). [More Information]
• Reijers, I., Rawson, R., Colebatch, A., Rozeman, E., Menzies, A., van Akkooi, A., Shannon, K., Wouters, M., Saw, R., van Houdt, W., Nieweg, O., Ch'ng, S., Spillane, A., Long, G., Scolyer, R., et al (2022). Representativeness of the Index Lymph Node for Total Nodal Basin in Pathologic Response Assessment after Neoadjuvant Checkpoint Inhibitor Therapy in Patients with Stage III Melanoma. JAMA Surgery, 157(4), 335-342. [More Information]
• Dieng, M., Lord, S., Turner, R., Nieweg, O., Menzies, A., Saw, R., Einstein, A., Emmett, L., Thompson, J., Lo, S., Morton, R. (2022). The Impact of Surveillance Imaging Frequency on the Detection of Distant Disease for Patients with Resected Stage III Melanoma. Annals of Surgical Oncology, 29(5), 2871-2881. [More Information]
• El Sharouni, M., Scolyer, R., van Gils, C., Ch'ng, S., Nieweg, O., Pennington, T., Saw, R., Shannon, K., Spillane, A., Stretch, J., Thompson, J., Lo, S., et al (2022). Time interval between diagnostic excision-biopsy of a primary melanoma and sentinel node biopsy: effects on the sentinel node positivity rate and survival outcomes. European Journal of Cancer, 167, 123-132. [More Information]

2021

• Nijhuis, A., Thompson, J., Nieweg, O. (2021). ASO Author Reflections: Ultrasound Assessment of the Lymphatic Drainage Area in Melanoma Patients With In-Transit Metastases. Annals of Surgical Oncology, 28(3), 1632-1633. [More Information]
• Li, A., Vakharia, K., Lo, S., Varey, A., Carlino, M., Saw, R., Shannon, K., Howle, J., Pennington, T., Stretch, J., Nieweg, O., Spillane, A., Long, G., Menzies, A., Scolyer, R., Thompson, J., Ch'ng, S. (2021). ASO Visual Abstract: Survival Outcomes of Salvage Metastasectomy after Failure of Modern-Era Systemic Therapy for Melanoma. Annals of Surgical Oncology, 28, 597-598. [More Information]
• Aivazian, K., Ahmed, T., El Sharouni, M., Stretch, J., Saw, R., Spillane, A., Shannon, K., Ch'ng, S., Nieweg, O., Thompson, J., Lo, S., Scolyer, R. (2021). Histological regression in melanoma: impact on sentinel lymph node status and survival. Modern Pathology, 34(11), 1999-2008. [More Information]
• Rawson, R., Adhikari, C., Bierman, C., Lo, S., Shklovskaya, E., Rozeman, E., Menzies, A., van Akkooi, A., Shannon, K., Gonzalez, M., Guminski, A., Stretch, J., Nieweg, O., Ch'ng, S., Rizos, H., Saw, R., Spillane, A., Wilmott, J., Long, G., Scolyer, R., et al (2021). Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma. Annals of Oncology, 32(6), 766-777. [More Information]
• Turner, R., Dieng, M., Khanna, N., Nguyen, M., Zeng, J., Nijhuis, A., Nieweg, O., Einstein, A., Emmett, L., Lord, S., Menzies, A., Thompson, J., Saw, R., Morton, R. (2021). Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA–D Melanoma. Annals of Surgical Oncology, 28(8), 4561-4569. [More Information]
• El Sharouni, M., Ahmed, T., Witkamp, A., Sigurdsson, V., van Gils, C., Nieweg, O., Scolyer, R., Thompson, J., van Diest, P., Lo, S. (2021). Predicting recurrence in patients with sentinel node-negative melanoma: validation of the EORTC nomogram using population-based data. British Journal of Surgery, 108(5), 550-553. [More Information]
• Ch'ng, S., Uyulmaz, S., Carlino, M., Pennington, T., Shannon, K., Rtshiladze, M., Stretch, J., Nieweg, O., Varey, A., Hsiao, E., Kapoor, R., Esteves Domingues Pires da Silva, I., Lo, S., Spillane, A., Scolyer, R., Long, G., Hong, A., Saw, R., Thompson, J., Menzies, A. (2021). Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. European Journal of Cancer, 153, 8-15. [More Information]
• Dieng, M., Lord, S., Nieweg, O., Saw, R., Einstein, A., Nijhuis, A., Turner, R., Thompson, J., Morton, R. (2021). Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al. Annals of Surgical Oncology, 28(Suppl 3), 819-820. [More Information]
• Thompson, J., Uren, R., Nieweg, O., Faries, M. (2021). Response to the Comment on "Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does Not Provide Reliable Staging: Results From a Large Multicenter Trial". Annals of Surgery, 274(1), e104-e105. [More Information]
• Rozeman, E., Hoefsmit, E., Reijers, I., Saw, R., Versluis, J., Krijgsman, O., Dimitriadis, P., Sikorska, K., van de Wiel, B., Eriksson, H., Gonzalez, M., Shannon, K., Stretch, J., Ch'ng, S., Nieweg, O., Spillane, A., Scolyer, R., et al (2021). Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma. Nature Medicine, 27(2), 256-263. [More Information]
• Li, A., Vakharia, K., Lo, S., Varey, A., Carlino, M., Saw, R., Shannon, K., Howle, J., Pennington, T., Stretch, J., Nieweg, O., Spillane, A., Long, G., Menzies, A., Scolyer, R., Thompson, J., Ch'ng, S. (2021). Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma. Annals of Surgical Oncology, 28(11), 6109-6123. [More Information]
• Berger, D., van den Berg, N., van der Noort, V., van der Hiel, B., Olmos, R., Buckle, T., KleinJan, G., Brouwer, O., Vermeeren, L., Karakullukçu, B., Nieweg, O., et al (2021). Technological (R)Evolution leads to detection of more sentinel nodes in patients with melanoma in the head and neck region. The Journal of Nuclear Medicine, 62(10), 1357-1362. [More Information]
• Nijhuis, A., Chung, D., London, K., Uren, R., Thompson, J., Nieweg, O. (2021). Ultrasound Examination of the Lymphatic Drainage Area and Regional Lymph Nodes in Melanoma Patients with In-Transit Metastases. Annals of Surgical Oncology, 28(3), 1625-1631. [More Information]

2020

• Gonzalez, M., Menzies, A., Pennington, T., Saw, R., Spillane, A., Stretch, J., Shannon, K., Ch'ng, S., Nieweg, O., Rojas, M., Lo, S., Scolyer, R., Long, G., et al (2020). A phase II study of neoadjuvant pembrolizumab and lenvatinib for resectable stage III melanoma: The neopele study. Journal of Clinical Oncology, 38(15), TPS10088. [More Information]
• Nijhuis, A., Nieweg, O. (2020). ASO Author Reflections: Melanoma Patients with a Local Recurrence or In-Transit Metastasis: Sentinel Node Biopsy to Identify Those at Highest Risk of Metastases and Death. Annals of Surgical Oncology, 27(2), 569-570. [More Information]
• Ipenburg, N., Nieweg, O., Lo, S. (2020). Author response to: Comment on: External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma. British Journal of Surgery, 107(5), 616. [More Information]
• Dieng, M., Khanna, N., Nguyen, M., Turner, R., Lord, S., Menzies, A., Allen, J., Saw, R., Nieweg, O., Thompson, J., Morton, R. (2020). Cost-effectiveness analysis of PET/CT surveillance imaging to detect systemic recurrence in resected stage III melanoma: Study protocol. BMJ Open, 10(11), 1-7. [More Information]
• Nijhuis, A., Spillane, A., Stretch, J., Saw, R., Menzies, A., Uren, R., Thompson, J., Nieweg, O. (2020). Current management of patients with melanoma who are found to be sentinel node-positive. ANZ Journal of Surgery, 90(4), 491-496. [More Information]
• Lo, S., Ma, J., Scolyer, R., Haydu, L., Stretch, J., Saw, R., Nieweg, O., Shannon, K., Spillane, A., Ch'ng, S., Mann, G., Thompson, J., Varey, A., et al (2020). Improved risk prediction calculator for sentinel node positivity in patients with melanoma: The melanoma institute australia nomogram. Journal of Clinical Oncology, 38(24), 2719-2727. [More Information]
• Uren, R., Nieweg, O., Thompson, J. (2020). Lymphoscintigraphy in Patients with Melanoma. In Not known (Eds.), Cutaneous Melanoma, Sixth Edition, (pp. 205-237). TBC. [More Information]
• Uppal, A., Stern, S., Thompson, J., Foshag, L., Mizzollo, N., Nieweg, O., Hoekstra, H., Roses, D., Sondak, V., Kashani-Sabet, M., et al (2020). Regional Node Basin Recurrence in Melanoma Patients: More Common After Node Dissection for Macroscopic Rather than Clinically Occult Nodal Disease. Annals of Surgical Oncology, 27(6), 1970-1977. [More Information]
• Nijhuis, A., Santos Filho, I., Holtkamp, L., Uren, R., Thompson, J., Nieweg, O. (2020). Sentinel Node Biopsy for Melanoma Patients with a Local Recurrence or In-Transit Metastasis. Annals of Surgical Oncology, 27(2), 561-568. [More Information]
• Holtkamp, L., Chakera, A., Fung, S., Stretch, J., Saw, R., Lee, K., Ch'ng, S., Gonzalez, M., Thompson, J., Emmett, L., Nieweg, O. (2020). Staging 18F-FDG PET/CT influences the treatment plan in melanoma patients with satellite or in-transit metastases. Melanoma Research, 30(4), 358-363. [More Information]
• Ipenburg, N., Lo, S., Vilain, R., Holtkamp, L., Wilmott, J., Nieweg, O., Thompson, J., Scolyer, R. (2020). The prognostic value of tumor mitotic rate in children and adolescents with cutaneous melanoma: A retrospective cohort study. Journal Of The American Academy Of Dermatology, 82(4), 910-919. [More Information]

2019

• Nijhuis, A., Ivan, I., Uren, R., Thompson, J., Nieweg, O. (2019). Clinical importance and surgical management of sentinel lymph nodes in the popliteal fossa of melanoma patients. European Journal of Surgical Oncology, 45(9), 1706-1711. [More Information]
• Friedman, E., Dodds, T., Lo, S., Ferguson, P., Beck, M., Saw, R., Stretch, J., Lee, K., Nieweg, O., Spillane, A., Scolyer, R., Thompson, J. (2019). Correlation Between Surgical and Histologic Margins in Melanoma Wide Excision Specimens. Annals of Surgical Oncology, 26(1), 25-32. [More Information]
• Ipenburg, N., Nieweg, O., Ahmed, T., van Doorn, R., Scolyer, R., Long, G., Thompson, J., Lo, S. (2019). External validation of a prognostic model to predict survival of patients with sentinel node-negative melanoma. British Journal of Surgery, 106(10), 1319-1326. [More Information]
• Nijhuis, A., Dieng, M., Khanna, N., Lord, S., Dalton, J., Menzies, A., Turner, R., Allen, J., Saw, R., Nieweg, O., Thompson, J., Morton, R. (2019). False-Positive Results and Incidental Findings with Annual CT or PET/CT Surveillance in Asymptomatic Patients with Resected Stage III Melanoma. Annals of Surgical Oncology, 26(6), 1860-1868. [More Information]
• Ipenburg, N., Thompson, J., Uren, R., Chung, D., Nieweg, O. (2019). Focused Ultrasound Surveillance of Lymph Nodes Following Lymphoscintigraphy Without Sentinel Node Biopsy: A Useful and Safe Strategy in Elderly or Frail Melanoma Patients. Annals of Surgical Oncology, 26(9), 2855-2863. [More Information]
• Rozeman, E., Menzies, A., van Akkooi, A., Adhikari, C., Bierman, C., van de Wiel, B., Scolyer, R., Krijgsman, O., Sikorska, K., Eriksson, H., Guminski, A., Shannon, K., Gonzalez, M., Ch'ng, S., Stretch, J., Nieweg, O., Saw, R., Spillane, A., Long, G., et al (2019). Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial. The Lancet Oncology, 20(7), 948-960. [More Information]
• Uren, R., Nieweg, O., Thompson, J. (2019). Lymphoscintigraphy in Patients with Melanoma. In Not known (Eds.), Cutaneous Melanoma, Sixth Edition, (pp. 1-33). TBC. [More Information]
• Long, G., Saw, R., Lo, S., Nieweg, O., Shannon, K., Gonzales, M., Guminski, A., Lee, J., Lee, H., Ferguson, P., Rawson, R., Wilmott, J., Thompson, J., Kefford, R., Ch'ng, S., Stretch, J., Rizos, H., Spillane, A., Scolyer, R., Menzies, A., et al (2019). Neoadjuvant dabrafenib combined with trametinib for resectable, stage IIIB-C, BRAFV600 mutation-positive melanoma (NeoCombi): a single-arm, open-label, single-centre, phase 2 trial. The Lancet Oncology, 20(7), 961-971. [More Information]

2018

• Vidal-Sicart, S., Valdes-Olmos, R., Nieweg, O., Faccini, R., Grootendorst, M., Wester, H., Navab, N., Vojnovic, B., van der Poel, H., Martinez-Roman, S., et al (2018). From interventionist imaging to intraoperative guidance: New perspectives by combining advanced tools and navigation with radio-guided surgery [De la imagen intervencionista a la guía intraoperatoria: nuevas perspectivas combinando herramientas avanzadas y navegación con la cirugía radioguiada]. Revista Espanola de Medicina Nuclear e Imagen Molecular, 37(1), 28-40. [More Information]
• Minkman, M., Bousema, L., Nieweg, O., Thio, H., Bousema, M. (2018). Nicotinamide for the prevention of nonmelanoma skin cancer [Nicotinamide ter preventie van non-melanoom huidkanker]. Nederlands Tijdschrift voor Dermatologie en Venereologie, 28(5), 41-44.
• Dodds, T., Lo, S., Jackett, L., Nieweg, O., Thompson, J., Scolyer, R. (2018). Prognostic Significance of Periadnexal Extension in Cutaneous Melanoma and its Implications for Pathologic Reporting and Staging. The American Journal of Surgical Pathology, 42(3), 359-366. [More Information]
• Isaksson, K., Nielsen, K., Mikiver, R., Nieweg, O., Scolyer, R., Thompson, J., Ingvar, C. (2018). Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts. Journal of Surgical Oncology, 118(4), 599-605. [More Information]
• Nieweg, O., Thompson, J., Cooper, A. (2018). The role of sentinel lymph node biopsy as a staging procedure in patients with melanoma - A critical appraisal. Australasian Journal of Dermatology, 59(3), 235-236. [More Information]
• Sladden, M., Nieweg, O., Howle, J., Coventry, B., Thompson, J. (2018). Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: Definitive excision margins for primary cutaneous melanoma. Medical Journal of Australia, 208(3), 137-142. [More Information]
• Sladden, M., Nieweg, O., Howle, J., Coventry, B., Thompson, J. (2018). Updated evidence-based clinical practice guidelines for the diagnosis and management of melanoma: definitive excision margins for primary cutaneous melanoma. Medical Journal of Australia, 208(3), 137-142.

2017

• Faries, M., Thompson, J., Cochran, A., Andtbacka, R., Mozzillo, N., Zager, J., Jahkola, T., Bowles, T., Testori, A., Beitsch, P., Nieweg, O., et al (2017). Completion dissection or observation for sentinel-node metastasis in melanoma. New England Journal of Medicine, 376(23), 2211-2222. [More Information]
• Holtkamp, L., Read, R., Emmett, L., Thompson, J., Nieweg, O. (2017). Futility of imaging to stage melanoma patients with a positive sentinel lymph node. Melanoma Research, 27(5), 457-462. [More Information]
• Nelson, D., Stern, S., Elashoff, D., Elashoff, R., Thompson, J., Mozzillo, N., Nieweg, O., Hoekstra, H., Cochran, A., Faires, M. (2017). Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma. Journal of the American College of Surgeons, 225(2), 302-311. [More Information]
• Ipenburg, N., Nieweg, O., Uren, R., Thompson, J. (2017). Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy. Annals of Surgical Oncology, 24(1), 117-126. [More Information]
• Holtkamp, L., Wang, S., Wilmott, J., Madore, J., Vilain, R., Thompson, J., Nieweg, O., Scolyer, R. (2017). Reply to comment on: Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (< 01 mm) Sentinel Lymph Node Metastases. Annals of Surgical Oncology, 24(Suppl3), 660. [More Information]
• Nieweg, O., Cooper, A., Thompson, J. (2017). Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal. Australasian Journal of Dermatology, 58(4), 268-273. [More Information]
• Jones, M., Jones, P., Stern, S., Elashoff, D., Hoon, D., Thompson, J., Mozzillo, N., Nieweg, O., Noyes, D., Hoekstra, H., et al (2017). The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma. Annals of Surgical Oncology, 24(8), 2089-2094. [More Information]

2016

• van den Berg, N., Engelen, T., Brouwer, O., Matheron, H., Valdes-Olmos, R., Nieweg, O., van Leeuwen, F. (2016). A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity. Nuclear Medicine Communications, 37(8), 812-817. [More Information]
• Uren, R., Nieweg, O., Thompson, J. (2016). Sentinel lymph node biopsy: Evolution of the technique since the original description by Morton et al. in 1992. Critical Reviews in Oncogenesis, 21(1-2), 7-17. [More Information]

2015

• Holtkamp, L., Wang, S., Wilmott, J., Madore, J., Vilain, R., Thompson, J., Nieweg, O., Scolyer, R. (2015). Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0,1mm) Sentinel Lymph Node Metastases. Annals of Surgical Oncology, 22(9), 2972-2977. [More Information]
• Bluemel, C., Herrmann, W., Giammarile, F., Nieweg, O., Dubreuil, J., Testori, A., Audisio, R., Zoras, O., Lassmann, S., Chakera, A., Uren, R., et al (2015). EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma. European Journal of Nuclear Medicine and Molecular Imaging, 42, 1750-1766. [More Information]
• van den Berg, N., Brouwer, O., Schaafsma, B., Matheron, H., Klop, W., Balm, A., van Tinteren, H., Nieweg, O., van Leeuwen, F., Valdes Olmos, R. (2015). Multimodal Surgical Guidance during Sentinel Node Biopsy for Melanoma: Combined Gamma Tracing and Fluorescence Imaging of the Sentinel Node through Use of the Hybrid Tracer Indocyanine Green-(99m)Tc-Nanocolloid. Radiology, 275(2), 521-529. [More Information]
• Nieweg, O., Uren, R., Thompson, J. (2015). The History of Sentinel Lymph Node Biopsy. The Cancer Journal, 21(1), 3-6. [More Information]
• de Bree, R., Nieweg, O. (2015). The history of sentinel node biopsy in head and neck cancer: From visualization of lymphatic vessels to sentinel nodes. Oral Oncology, 51(9), 819-823. [More Information]

2014

• Morton, D., Thompson, J., Cochran, A., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., Puleo, C., Coventry, B., et al (2014). Final trial report of sentinel-node biopsy versus nodal observation in melanoma. New England Journal of Medicine, 370(7), 599-609. [More Information]
• Nieweg, O., Thompson, J. (2014). Sentinel node biopsy is now part of routine staging in patients with clinically localized melanoma. ANZ Journal of Surgery, 84(10), 701-702. [More Information]

2012

• Howard, J., Thompson, J., Mozzillo, N., Nieweg, O., Hoekstra, H., Roses, D., Sondak, V., Reintgen, D., Kashani-Sabet, M., Karakousis, C., et al (2012). Metastasectomy for Distant Metastatic Melanoma: Analysis of Data from the First Multicenter Selective Lymphadenectomy Trial (MSLT-I). Annals of Surgical Oncology, 19(8), 2547-2555. [More Information]

2010

• Faries, M., Thompson, J., Cochrane, A., Elashoff, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., et al (2010). The Impact on Morbidity and Length of Stay of Early Versus Delayed Complete Lymphadenectomy in Melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Annals of Surgical Oncology, 17, 3324-3329. [More Information]

2006

• Morton, D., Thompson, J., Cochran, A., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O., Roses, D., Hoekstra, H., Karakousis, C., et al (2006). Sentinel-node biopsy or nodal observation in melanoma. New England Journal of Medicine, 355(13), 1307-1317. [More Information]

2005

• Morton, D., Cochran, A., Thompson, J., Elashoff, R., Essner, R., Glass, E., Mozzillo, N., Nieweg, O., Roses, D., Hoekstra, H., et al (2005). Sentinel Node Biopsy for Early-Stage Melanoma Accuracy and Morbidity in MSLT-I, an International Multicenter Trial. Annals of Surgery, 242(3), 302-313. [More Information]

2004

• de Vries, J., Nieweg, O., Uren, R. (2004). Position Emission Tomography. In John F Thompson, Donald L Morton, Bin BR Kroon (Eds.), Textbook of Melanoma, (pp. 477-481). London: Martin Dunitz.